Cargando…

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis

This study was undertaken to investigate idiopathic pulmonary fibrosis (IPF) patients' health-related quality of life (HRQoL) and symptoms in a real-life cross-sectional study. Our secondary aim was to create a simple identification method for patients with increased need for palliative care by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajala, Kaisa, Lehto, Juho T., Sutinen, Eva, Kautiainen, Hannu, Myllärniemi, Marjukka, Saarto, Tiina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731772/ https://www.ncbi.nlm.nih.gov/pubmed/29255720 http://dx.doi.org/10.1183/23120541.00084-2017

Ejemplares similares

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
por: Seppälä, Severi, et al.
Publicado: (2020)

End-of-life care of patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2016)

Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life
por: Rajala, K., et al.
Publicado: (2018)

Differences in physical activity according to mMRC grade in patients with COPD
por: Hayata, Atsushi, et al.
Publicado: (2016)

Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study
por: Huang, Wei-Chang, et al.
Publicado: (2015)

Evaluation of the Individual Activity Descriptors of the mMRC Breathlessness Scale: A Mixed Method Study
por: Yorke, Janelle, et al.
Publicado: (2022)

Association between body mass index and patient-reported-outcome questionnaire scores (CAT™, ACT™, mMRC dyspnoea scale, IPAQ) in Ukraine, Kazakhstan and Azerbaijan: results of the CORE study
por: Nugmanova, D., et al.
Publicado: (2021)

How to Utilize CAT and mMRC Scores to Assess Symptom Status of Patients with COPD in Clinical Practice?
por: ERTAN YAZAR, Esra, et al.
Publicado: (2022)

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
por: Hollmén, Maria, et al.
Publicado: (2023)

Little agreement in GOLD category using CAT and mMRC in 450 primary care COPD patients in New Zealand
por: Holt, Shaun, et al.
Publicado: (2014)

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways
por: Saraswat, Mayank, et al.
Publicado: (2020)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Dyspnoea with progressive “idiopathic” pulmonary fibrosis
por: Puri, Chahat, et al.
Publicado: (2021)

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD
por: Ishikawa, Nobuhisa, et al.
Publicado: (2010)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine
por: Koli, Katri, et al.
Publicado: (2016)

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
por: Kaunisto, Jaana, et al.
Publicado: (2013)

Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses
por: Kim, Sunmin, et al.
Publicado: (2013)

The required competencies of physicians within palliative care from the perspectives of multi-professional expert groups: a qualitative study
por: Melender, Hanna-Leena, et al.
Publicado: (2020)

Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland
por: Kaunisto, Jaana, et al.
Publicado: (2023)

Undergraduate curriculum in palliative medicine at Tampere University increases students’ knowledge
por: Lehto, Juho T., et al.
Publicado: (2017)

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
por: Pesonen, Ida, et al.
Publicado: (2018)

Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models
por: Myllärniemi, Marjukka, et al.
Publicado: (2014)

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
por: Bendstrup, Elisabeth, et al.
Publicado: (2015)

The MRC Dyspnoea Scale and mortality risk prediction in pulmonary arterial hypertension: A retrospective longitudinal cohort study
por: Arogundade, Folawemimo, et al.
Publicado: (2023)

Are physicians in primary health care able to recognize pulmonary fibrosis?
por: Purokivi, Minna, et al.
Publicado: (2017)

Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis
por: Kaunisto, Jaana, et al.
Publicado: (2015)

Progressive dyspnoea in a patient with idiopathic non-cirrhotic portal hypertension
por: Cullivan, Sarah, et al.
Publicado: (2022)

Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled BREX exercise study
por: Roine, Eija, et al.
Publicado: (2021)

Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics
por: Partanen, Juulia J., et al.
Publicado: (2022)

Phlebolith with dyspnoea
por: Mani, Ashwin K., et al.
Publicado: (2020)

MRC2020: improvements to Ximdisp and the MRC image-processing programs
por: Short, J. M., et al.
Publicado: (2023)

Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells
por: Invernizzi, F., et al.
Publicado: (2012)

Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD
por: Rytilä, Paula, et al.
Publicado: (2006)

Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12
por: Yorke, J, et al.
Publicado: (2010)

The impact of the duration of the palliative care period on cancer patients with regard to the use of hospital services and the place of death: a retrospective cohort study
por: Hirvonen, Outi M., et al.
Publicado: (2020)

Dyspnœa in Heart Disease
por: Barrie,
Publicado: (1910)

Acute Intermittent Dyspnœa
Publicado: (1829)

Exertional dyspnoea in obesity
por: Bernhardt, Vipa, et al.
Publicado: (2016)

Dyspnœa on Falling Asleep
por: Ballard, E. A.
Publicado: (1882)

Cannot write session to /tmp/vufind_sessions/sess_p1q9dd8mue8b2m0tbh7ehbbf7r